How to Buy Doximity Stock
Doximity Inc
Doximity is a health information service company located in California, United States, which is part of the Healthcare sector, and is traded under the ticker DOCS on the NYSE exchange.
Doximity stock last closed at $24.13, down 0.33% from the previous day, and has decreased 30.58% in one year. It has underperformed other stocks in the Health Information Services industry by 0.17 percentage points. Doximity stock is currently +22.43% from its 52-week low of $19.71, and -39.86% from its 52-week high of $40.12.
There are currently 185.91M DOCS shares outstanding. The market cap of DOCS is $4.49B. In the past 24 hours, 1.44M DOCS shares were traded.
How to Buy Doximity Stock
Wondering how to invest in Doximity stock? Here's how.
- Choose where to buy Doximity stock: You need to choose an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Doximity stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Choose your method of payment and add your info.
- Analyze Doximity stock: The Doximity ticker symbol is DOCS. Is Doximity stock a good investment? Should you buy shares of DOCS? How do DOCS's underlying business fundamentals look? Do top analysts think Doximity is a good buy? Why has DOCS's stock price moved recently? (Hint: Our stock market research website can help you understand if DOCS is a good stock to buy).
- Place your DOCS trade: Decide if you will purchase DOCS shares at the current market price or use a limit order to buy DOCS shares at a particular price.
- Get the latest news on your investment in DOCS: Create a watchlist to track your new investment in Doximity shares.
Step 1: Choose where to buy Doximity stock
You will need a brokerage account to access the NYSE market and buy DOCS shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Financial Services, New York to Hong Kong — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro today.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you can invest in DOCS stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new trading account.
- Send your details by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have opened your account on our top ranked stock market app, you need to deposit funds:
Watch the walkthrough below to see the process of transferring funds into your investment account.
Step 4: Analyze Doximity stock
Once you have decided on the best place to buy Doximity stock, it's absolutely critical to research their stock prior to investing, so you can wrap your head around the risk as well as the opportunity.
Overview of key DOCS info
Doximity Due Diligence Checks
WallStreetZen was built to help average investors perform more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on DOCS's stock page.
How is DOCS stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge DOCS's fair value.
Using relative valuations ratios:
- DOCS could be overvalued based on its P/E ratio of 38.3x, relative to Health Information Services industry P/E ratio of 23.72x
- DOCS may be overvalued based on its P/B ratio of 5.15x, relative to Health Information Services industry P/B ratio of 2.99x
- DOCS could be overvalued based on its PEG ratio of 2.36x
You can access more valuation analysis on DOCS's stock here.
DOCS Financial Health
Passed Health Checks:
- DOCS has a low debt to equity ratio of 0.18.
- DOCS earnings of $151.88M is not sufficient to cover its interest payments.
- DOCS's operating cash flow of $165.43M allows it to safely service it's debt of $15.05M.
- There are more short-term assets than long-term liabilities on the DOCS balance sheet.
- There are more short-term assets than short-term liabilities on the DOCS balance sheet.
Failed Health Checks:
- DOCS profit margin has gone down from 36.8% to 27.5% in the past year.
Do analysts think it's a good time to buy DOCS stock
Out of 6 Wall Street analysts who monitor DOCS, the consensus analyst rating on Doximity is a Hold
Please note that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent DOCS Analyst Upgrades/Downgrades
Brian Peterson, a bottom 10% analyst from Raymond James maintains DOCS with a buy rating and lowers their DOCS price target from $40.00 to $30.00, on Aug 9, 2023.
You can dig deeper into what analysts are forecasting on the Doximity stock forecast page.
DOCS Momentum
How is DOCS performing as a company?
Last year, DOCS earnings were $123.14M. In the past two year, DOCS's earnings have grown by 10.07% per year. This was faster than the Health Information Services industry average of 4.54%.
Last year, DOCS revenue was $448.31M. Over the last two year, DOCS's revenue has increased by 27.12% per year. This was faster than the Health Information Services industry average of 23.75%.
Learn more about DOCS's earnings and revenue performance here.
Are DOCS executives and large shareholders buying or selling the stock?
In the past 12 months, insiders at DOCS have sold more shares than they have bought.
Kira Scherer Wampler, Director of DOCS, was the latest DOCS insider to sell. They sold $61,025.00 worth of DOCS shares on Nov 24, 2023.
Learn more about who owns DOCS shares here.
Can I get consistent income from DOCS stock?
No, Doximity doesn't provide an income stream by paying out dividends.
What others are saying about DOCS
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your DOCS trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you need more help buying stocks on eToro, click the helpful video below:
Step 6: Get the latest news on your investment in DOCS
Now that you own some DOCS shares, you'll want to stay up-to-date on your investment.
Put DOCS on a watchlist to get notified of the latest news about your DOCS stock.
DOCS Feed
How to Buy Stock in Doximity
To summarize, here are the 6 steps you need to take to buy Doximity stock right now:
- Choose where to buy Doximity stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Analyze Doximity stock
- Place your DOCS trade
- Get the latest news on your investment in DOCS
If you need a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get updates on your new investment in Doximity, click the button below.
Related Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.